"Hemangioma, Capillary" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A dull red, firm, dome-shaped hemangioma, sharply demarcated from surrounding skin, usually located on the head and neck, which grows rapidly and generally undergoes regression and involution without scarring. It is caused by proliferation of immature capillary vessels in active stroma, and is usually present at birth or occurs within the first two or three months of life. (Dorland, 27th ed)
Descriptor ID |
D018324
|
MeSH Number(s) |
C04.557.645.375.380
|
Concept/Terms |
Hemangioma, Capillary- Hemangioma, Capillary
- Capillary Hemangioma
- Capillary Hemangiomas
- Hemangiomas, Capillary
|
Below are MeSH descriptors whose meaning is more general than "Hemangioma, Capillary".
Below are MeSH descriptors whose meaning is more specific than "Hemangioma, Capillary".
This graph shows the total number of publications written about "Hemangioma, Capillary" by people in this website by year, and whether "Hemangioma, Capillary" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2013 | 1 | 0 | 1 |
2017 | 0 | 1 | 1 |
2021 | 1 | 0 | 1 |
2022 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hemangioma, Capillary" by people in Profiles.
-
Hemangioma Genetics and Associated Syndromes. Dermatol Clin. 2022 Oct; 40(4):393-400.
-
Should Propranolol Remain the Gold Standard for Treatment of Infantile Hemangioma? A Systematic Review and Meta-Analysis of Propranolol Versus Atenolol. Ann Otol Rhinol Laryngol. 2023 Mar; 132(3):332-340.
-
Clinical Features, Prognostic Factors, and Treatment Interventions for Ulceration in Patients With Infantile Hemangioma. JAMA Dermatol. 2021 05 01; 157(5):566-572.
-
State-of-the-art lasers and light treatments for vascular lesions: from red faces to vascular malformations. Semin Cutan Med Surg. 2017 Dec; 36(4):207-212.
-
Vascular tumors have increased p70 S6-kinase activation and are inhibited by topical rapamycin. Lab Invest. 2013 Oct; 93(10):1115-27.